AIRC project IG 2017

Project objectives

• Implementation of a nanoparticle-based test for the identification of patients with pancreatic adenocarcinoma
• Development and patenting of an integrated platform for the early diagnosis of pancreatic adenocarcinoma

Start and end date

02/01/2018 - 01/01/2023

Project Manager

Prof. Roberto Coppola, Dr. Damiano Caputo (Patient recruitment, analysis and interpretation of the results obtained during the trial)

Coordinating institution of the project

Sapienza University of Rome

Other Institutions involved

• Harvard Medical School
• Catholic University of Sacred Heart